Skip to content
Sectors How it works Pricing Client stories

Insights

Companies Live signals Events Markets Trends Company lists
Log in
Platform Signal Tracker API Radar Book a 7-day Readout
Qritive logo — Qritive makes cancer diagnostics fast, accurate, and afforda...

Qritive

Qritive makes cancer diagnostics fast, accurate, and affordable

Founded 2017 Singapore Singapore 17 employees Non Equity Assistance Total: $9.00M AI, Biotechnology +2

General Information

Company Name Qritive
Founded Year 2017
Location Singapore Singapore
Employees 17
Industries AI, Biotechnology, Health Care +1
Funding Stage Non Equity Assistance
Social

BounceWatch is an independent company data service, not affiliated with Qritive. To contact Qritive, visit qritive.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Qritive compare?

A PDF of Qritive and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Qritive soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About Qritive

Qritive is a Singapore-based startup that focuses on revolutionizing cancer diagnostics. The company's slogan "Qritive makes cancer diagnostics fast, accurate, and affordable" encapsulates its core mission. Leveraging AI-powered solutions, Qritive aims to enable histopathologic diagnosis of cancer at scale, ultimately delivering faster and more cost-effective results of high accuracy. The company offers a clinical-decision support system for pathologists, enhancing efficiency and quality in diagnosis and consequently leading to better patient outcomes. Qritive's digital pathology platform has garnered attention and adoption from several healthcare institutions in Singapore, India, Morocco, UAE, and the USA. The startup's achievements have been showcased at prestigious events and published in renowned journals, including USCAP 2023, 2022, and 2021, along with a feature in Nature Scientific Report. Founded in 2017, Qritive operates at the intersection of Biotechnology, Health Care, and Information Technology, reflecting its interdisciplinary approach to solving critical medical challenges. The startup recently received a non-equity assistance investment on 29 May 2024, with MedTech Innovator as the contributing investor. With its innovative solutions and successful track record, Qritive stands as a promising player in the biotechnology and healthcare industries, poised to make a significant impact on the future of cancer diagnostics.

Business keywords: cancer diagnostics, AI-powered solution, microscopy images, patient data analysis, cost-effective diagnostics, automated tools, efficiency in diagnosis, medical imaging, precision medicine, diagnostic accuracy, disease detection

Funding Rounds & Investors (6)

View All
Funding Stage Amount Investors Lead Investors Date
Non Equity Assistance Undisclosed 1
MedTech Innovator
MedTech Innovator
29 May 2024
Series A $7.50M 3
Exfinity Technology Fund SEEDS Capital
Exfinity Technology Fund, SEEDS Capital +1
09 Jan 2023
Series A Undisclosed 1
MassMutual Ventures
MassMutual Ventures
01 Jan 2021
Seed Round $1.50M 2
SGInnovate Pix Vine Capital
SGInnovate, Pix Vine Capital
31 Dec 2019
Seed Round Undisclosed 1
Acequia Capital (AceCap)
17 Dec 2018
Convertible Note Undisclosed 1
SGInnovate
SGInnovate
01 Feb 2018

Qritive Alternatives & Competitors

View All Alternatives
Qritive vs
Orbuculum Genolytics Pvt Ltd
Orbuculum Genolytics Pvt Ltd India

Future of Healthcare, Healthcare of Future

5 employees
AI, Biotechnology
Compare Qritive vs Orbuculum Genolytics Pvt Ltd
Qritive vs
Sanome
Sanome United Kingdom

Closing the gap between data and decision in healthcare - making hospitals safer, smarter and more e...

Pre-Seed
30 employees
Biotechnology, Health Care
Compare Qritive vs Sanome
Qritive vs
Cleveland Diagnostics
Cleveland Diagnostics United States

Cleveland Diagnostics is a cancer biotechnology company that is changing the shape of cancer detecti...

Private Equity
76 employees
Biotechnology, Health Care
View all alternatives

FAQ About Qritive

Qritive makes cancer diagnostics fast, accurate, and affordable
Qritive was founded in 2017.
Qritive is headquartered in Singapore.
Qritive operates in AI, Biotechnology, Health Care and Information Technology. Its work centres on cancer diagnostics, AI-powered solution, microscopy images and patient data analysis.
Qritive has approximately 17 employees.
Qritive has completed 6 funding rounds, raising a total of $9.00M. The latest funding stage is Non Equity Assistance.
Top alternatives and competitors to Qritive include Orbuculum Genolytics Pvt Ltd, Sanome, Cleveland Diagnostics, Craif Inc., bioAffinity Technologies. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Qritive and Orbuculum Genolytics Pvt Ltd are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Qritive, https://bouncewatch.com/company/qritive, updated 19 December 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Talk to an analyst Book a 7-day Readout